{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:34:58Z","timestamp":1794339298709,"version":"4.9.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T00:00:00Z","timestamp":1632355200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AI 148802"],"award-info":[{"award-number":["R01 AI 148802"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI158719"],"award-info":[{"award-number":["R01AI158719"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM101183"],"award-info":[{"award-number":["R01GM101183"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 AI 151344"],"award-info":[{"award-number":["R21 AI 151344"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009727","name":"Hospital Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP2003712"],"award-info":[{"award-number":["APP2003712"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001780","name":"RMIT University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.xcrm.2021.100423","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T05:38:05Z","timestamp":1634881085000},"page":"100423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Host-directed therapy, an untapped opportunity for antimalarial intervention"],"prefix":"10.1016","volume":"2","author":[{"given":"Ling","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8415-7539","authenticated-orcid":false,"given":"Jack","family":"Adderley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5594-3204","authenticated-orcid":false,"given":"Didier","family":"Leroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Drewry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danny W.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Kaushansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Doerig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2021.100423_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1128\/CMR.00030-10","article-title":"Challenges of antibacterial discovery","volume":"24","author":"Silver","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.xcrm.2021.100423_bib2","first-page":"677","article-title":"An enzyme from bacteria able to destroy penicillin. 1940","volume":"10","author":"Abraham","year":"1988","journal-title":"Rev. Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100423_bib3","doi-asserted-by":"crossref","first-page":"62","DOI":"10.4269\/ajtmh.1996.54.62","article-title":"Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand","volume":"54","author":"Looareesuwan","year":"1996","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.xcrm.2021.100423_bib4","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1128\/AAC.44.8.2100-2108.2000","article-title":"Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site","volume":"44","author":"Korsinczky","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.xcrm.2021.100423_bib5","doi-asserted-by":"crossref","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","article-title":"Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria","volume":"85","author":"Peterson","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100423_bib6","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1038\/s41564-019-0551-1","article-title":"Enterovirus pathogenesis requires the host methyltransferase SETD3","volume":"4","author":"Diep","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100423_bib7","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.3389\/fmicb.2018.02655","article-title":"Host-Directed Drug Therapies for Neglected Tropical Diseases Caused by Protozoan Parasites","volume":"9","author":"Varikuti","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100423_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.micpath.2019.03.003","article-title":"Host-directed therapies to combat tuberculosis and associated non-communicable diseases","volume":"130","author":"Baindara","year":"2019","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.xcrm.2021.100423_bib9","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/jiy552","article-title":"The Potent ITK\/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani","volume":"219","author":"Varikuti","year":"2019","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100423_bib10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2174\/138161213804070276","article-title":"Targeting host factors to circumvent anti-malarial drug resistance","volume":"19","author":"Prudencio","year":"2013","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.xcrm.2021.100423_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.bbapap.2009.10.009","article-title":"Malaria: targeting parasite and host cell kinomes","volume":"1804","author":"Doerig","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.xcrm.2021.100423_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.molbiopara.2016.05.006","article-title":"The ins and outs of phosphosignalling in Plasmodium: parasite regulation and host cell manipulation","volume":"208","author":"Carvalho","year":"2016","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.xcrm.2021.100423_bib13","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.pt.2018.07.011","article-title":"Opportunities for Host-targeted Therapies for Malaria","volume":"34","author":"Glennon","year":"2018","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.xcrm.2021.100423_bib14","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pt.2021.01.002","article-title":"Parasite and host erythrocyte kinomics of Plasmodium infection","volume":"37","author":"Adderley","year":"2021","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.xcrm.2021.100423_bib15","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.reprotox.2020.06.013","article-title":"Review of embryo-fetal developmental toxicity studies performed for pharmaceuticals approved by FDA in 2018 and 2019","volume":"99","author":"Barrow","year":"2021","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.xcrm.2021.100423_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12936-016-1675-x","article-title":"New developments in anti-malarial target candidate and product profiles","volume":"16","author":"Burrows","year":"2017","journal-title":"Malar. J."},{"key":"10.1016\/j.xcrm.2021.100423_bib17","doi-asserted-by":"crossref","first-page":"e1004871","DOI":"10.1371\/journal.ppat.1004871","article-title":"Targeting Human Transmission Biology for Malaria Elimination","volume":"11","author":"Nilsson","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2021.100423_bib18","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/nm947","article-title":"Hepatocyte growth factor and its receptor are required for malaria infection","volume":"9","author":"Carrolo","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100423_bib19","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.chom.2008.07.012","article-title":"Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection","volume":"4","author":"Rodrigues","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2021.100423_bib20","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.celrep.2013.02.010","article-title":"Suppression of host p53 is critical for Plasmodium liver-stage infection","volume":"3","author":"Kaushansky","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2021.100423_bib21","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/mt.2015.18","article-title":"Host-based Prophylaxis Successfully Targets Liver Stage Malaria Parasites","volume":"23","author":"Douglass","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.xcrm.2021.100423_bib22","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/s41467-017-01345-2","article-title":"Identifying host regulators and inhibitors of liver stage malaria infection using kinase activity profiles","volume":"8","author":"Arang","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100423_bib23","doi-asserted-by":"crossref","first-page":"e1007057","DOI":"10.1371\/journal.ppat.1007057","article-title":"Plasmodium parasite exploits host aquaporin-3 during liver stage malaria infection","volume":"14","author":"Posfai","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2021.100423_bib24","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.chembiol.2019.05.011","article-title":"Discovery of Druggable Host Factors Critical to Plasmodium Liver-Stage Infection","volume":"26","author":"Raphemot","year":"2019","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.xcrm.2021.100423_bib25","doi-asserted-by":"crossref","first-page":"e762","DOI":"10.1038\/cddis.2013.286","article-title":"Malaria parasite liver stages render host hepatocytes susceptible to mitochondria-initiated apoptosis","volume":"4","author":"Kaushansky","year":"2013","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2021.100423_bib26","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1182\/blood-2007-04-084582","article-title":"Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins","volume":"110","author":"Gillrie","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100423_bib27","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1086\/528988","article-title":"Rho kinase inhibition in severe malaria: thwarting parasite-induced collateral damage to endothelia","volume":"197","author":"Taoufiq","year":"2008","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100423_bib28","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/j.1462-5822.2011.01582.x","article-title":"Activation of a PAK-MEK signalling pathway in malaria parasite-infected erythrocytes","volume":"13","author":"Sicard","year":"2011","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100423_bib29","doi-asserted-by":"crossref","first-page":"e0164895","DOI":"10.1371\/journal.pone.0164895","article-title":"Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia","volume":"11","author":"Kesely","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100423_bib30","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1038\/s41467-020-17829-7","article-title":"Analysis of erythrocyte signalling pathways during Plasmodium falciparum infection identifies targets for host-directed antimalarial intervention","volume":"11","author":"Adderley","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100423_bib31","doi-asserted-by":"crossref","first-page":"e528","DOI":"10.1371\/journal.pmed.0030528","article-title":"Erythrocyte G protein as a novel target for malarial chemotherapy","volume":"3","author":"Murphy","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.xcrm.2021.100423_bib32","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41418-019-0338-1","article-title":"Liver stage malaria infection is controlled by host regulators of lipid peroxidation","volume":"27","author":"Kain","year":"2020","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2021.100423_bib33","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.aaa3526","article-title":"Malaria. A forward genetic screen identifies erythrocyte CD55 as essential for Plasmodium falciparum invasion","volume":"348","author":"Egan","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100423_bib34","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pt.2016.12.011","article-title":"Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses","volume":"33","author":"White","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.xcrm.2021.100423_bib35","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00011-19","article-title":"8-Aminoquinoline Therapy for Latent Malaria","volume":"32","author":"Baird","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.xcrm.2021.100423_bib36","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2147\/IDR.S151031","article-title":"Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data","volume":"12","author":"Hounkpatin","year":"2019","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.xcrm.2021.100423_bib37","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/nm808","article-title":"Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity","volume":"9","author":"Silvie","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100423_bib38","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.aad3318","article-title":"Malaria parasites target the hepatocyte receptor EphA2 for successful host infection","volume":"350","author":"Kaushansky","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100423_bib39","doi-asserted-by":"crossref","first-page":"e0200032","DOI":"10.1371\/journal.pone.0200032","article-title":"Plasmodium sporozoites can invade hepatocytic cells independently of the Ephrin receptor A2","volume":"13","author":"Langlois","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100423_bib40","doi-asserted-by":"crossref","first-page":"e25903","DOI":"10.7554\/eLife.25903","article-title":"Plasmodium P36 determines host cell receptor usage during sporozoite invasion","volume":"6","author":"Manzoni","year":"2017","journal-title":"eLife"},{"key":"10.1016\/j.xcrm.2021.100423_bib41","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nm.2456","article-title":"The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species","volume":"17","author":"Kaushansky","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100423_bib42","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ijpara.2007.01.002","article-title":"L-FABP is a critical host factor for successful malaria liver stage development","volume":"37","author":"Mikolajczak","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.xcrm.2021.100423_bib43","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.chom.2014.11.006","article-title":"Host cell phosphatidylcholine is a key mediator of malaria parasite survival during liver stage infection","volume":"16","author":"Itoe","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2021.100423_bib44","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1600-0854.2012.01398.x","article-title":"The host endocytic pathway is essential for Plasmodium berghei late liver stage development","volume":"13","author":"Lopes da Silva","year":"2012","journal-title":"Traffic"},{"key":"10.1016\/j.xcrm.2021.100423_bib45","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/s41598-019-44449-z","article-title":"Deciphering host lysosome-mediated elimination of Plasmodium berghei liver stage parasites","volume":"9","author":"Niklaus","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2021.100423_bib46","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.isci.2019.10.054","article-title":"Plasmodium Secretion Induces Hepatocyte Lysosome Exocytosis and Promotes Parasite Entry","volume":"21","author":"Vijayan","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.xcrm.2021.100423_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.chom.2015.10.006","article-title":"Malaria Sporozoites Traverse Host Cells within Transient Vacuoles","volume":"18","author":"Risco-Castillo","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.xcrm.2021.100423_bib48","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1462-5822.2010.01555.x","article-title":"Plasmodium salvages cholesterol internalized by LDL and synthesized de novo in the liver","volume":"13","author":"Labaied","year":"2011","journal-title":"Cell Microbiol."},{"key":"10.1016\/j.xcrm.2021.100423_bib49","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41564-017-0054-x","article-title":"Plasmodium UIS3 sequesters host LC3 to avoid elimination by autophagy in hepatocytes","volume":"3","author":"Real","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100423_bib50","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1091\/mbc.e16-07-0531","article-title":"Sequestration of cholesterol within the host late endocytic pathway restricts liver-stage Plasmodium development","volume":"28","author":"Petersen","year":"2017","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.xcrm.2021.100423_bib51","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.chembiol.2020.03.009","article-title":"Plasmodium vivax Liver and Blood Stages Recruit the Druggable Host Membrane Channel Aquaporin-3","volume":"27","author":"Posfai","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.xcrm.2021.100423_bib52","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2019.03.006","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors","volume":"144","author":"Roskoski","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2021.100423_bib53","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/nrd.2018.21","article-title":"Kinase inhibitors: the road ahead","volume":"17","author":"Ferguson","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2021.100423_bib54","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1182\/bloodadvances.2018023515","article-title":"Absolute proteome quantification of highly purified populations of circulating reticulocytes and mature erythrocytes","volume":"2","author":"Gautier","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.xcrm.2021.100423_bib55","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.1089324","article-title":"Erythrocyte G protein-coupled receptor signaling in malarial infection","volume":"301","author":"Harrison","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100423_bib56","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1182\/blood-2016-11-748053","article-title":"Syk inhibitors interfere with erythrocyte membrane modification during P falciparum growth and suppress parasite egress","volume":"130","author":"Pantaleo","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100423_bib57","doi-asserted-by":"crossref","first-page":"e0242372","DOI":"10.1371\/journal.pone.0242372","article-title":"Identification of tyrosine kinase inhibitors that halt Plasmodium falciparum parasitemia","volume":"15","author":"Kesely","year":"2020","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100423_bib58","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pt.2016.11.004","article-title":"EPCR and Malaria Severity: The Center of a Perfect Storm","volume":"33","author":"Bernabeu","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.xcrm.2021.100423_bib59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.molbiopara.2014.07.006","article-title":"The role of PfEMP1 adhesion domain classification in Plasmodium falciparum pathogenesis research","volume":"195","author":"Smith","year":"2014","journal-title":"Mol. Biochem. Parasitol."},{"issue":"3, Suppl","key":"10.1016\/j.xcrm.2021.100423_bib60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4269\/ajtmh.14-0841","article-title":"Investigating the Pathogenesis of Severe Malaria: A Multidisciplinary and Cross-Geographical Approach","volume":"93","author":"Wassmer","year":"2015","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.xcrm.2021.100423_bib61","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1056\/NEJMoa1400116","article-title":"Brain swelling and death in children with cerebral malaria","volume":"372","author":"Seydel","year":"2015","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100423_bib62","doi-asserted-by":"crossref","first-page":"13615","DOI":"10.1074\/jbc.M116.770313","article-title":"Small molecule-based inhibition of MEK1\/2 proteins dampens inflammatory responses to malaria, reduces parasite load, and mitigates pathogenic outcomes","volume":"292","author":"Wu","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.xcrm.2021.100423_bib63","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s12974-018-1147-z","article-title":"Neuregulin-1 attenuates experimental cerebral malaria (ECM) pathogenesis by regulating ErbB4\/AKT\/STAT3 signaling","volume":"15","author":"Liu","year":"2018","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.xcrm.2021.100423_bib64","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.immuni.2019.08.009","article-title":"A Molecular Signature in Blood Reveals a Role for p53 in Regulating Malaria-Induced Inflammation","volume":"51","author":"Tran","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100423_bib65","doi-asserted-by":"crossref","first-page":"472","DOI":"10.3390\/microorganisms8040472","article-title":"High-Throughput Screening of the ReFRAME Library Identifies Potential Drug Repurposing Candidates for Trypanosoma cruzi","volume":"8","author":"Bernatchez","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.xcrm.2021.100423_bib66","doi-asserted-by":"crossref","first-page":"10750","DOI":"10.1073\/pnas.1810137115","article-title":"The ReFRAME library as a comprehensive drug repurposing library and its application to the treatment of cryptosporidiosis","volume":"115","author":"Janes","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100423_bib67","doi-asserted-by":"crossref","first-page":"e0008353","DOI":"10.1371\/journal.pntd.0008353","article-title":"Discovery of repurposing drug candidates for the treatment of diseases caused by pathogenic free-living amoebae","volume":"14","author":"Rice","year":"2020","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.xcrm.2021.100423_bib68","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3390\/v12091041","article-title":"Identification of Inhibitors of ZIKV Replication","volume":"12","author":"Morales Vasquez","year":"2020","journal-title":"Viruses"},{"key":"10.1016\/j.xcrm.2021.100423_bib69","doi-asserted-by":"crossref","first-page":"104558","DOI":"10.1016\/j.antiviral.2019.104558","article-title":"The ReFRAME library as a comprehensive drug repurposing library to identify mammarenavirus inhibitors","volume":"169","author":"Kim","year":"2019","journal-title":"Antiviral Res."},{"key":"10.1016\/j.xcrm.2021.100423_bib70","doi-asserted-by":"crossref","first-page":"104609","DOI":"10.1016\/j.phrs.2019.104609","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2020 update","volume":"152","author":"Roskoski","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2021.100423_bib71","doi-asserted-by":"crossref","first-page":"105463","DOI":"10.1016\/j.phrs.2021.105463","article-title":"Properties of FDA-approved small molecule protein kinase inhibitors: a 2021 update","volume":"165","author":"Roskoski","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.xcrm.2021.100423_bib72","doi-asserted-by":"crossref","first-page":"908","DOI":"10.3390\/molecules23040908","article-title":"PKIDB: A Curated, Annotated and Updated Database of Protein Kinase Inhibitors in Clinical Trials","volume":"23","author":"Carles","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.xcrm.2021.100423_bib75","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acschemneuro.0c00176","article-title":"Defining the Neural Kinome: Strategies and Opportunities for Small Molecule Drug Discovery to Target Neurodegenerative Diseases","volume":"11","author":"Krahn","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.xcrm.2021.100423_bib76","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1021\/acs.jmedchem.0c01511","article-title":"Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases","volume":"64","author":"Xie","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2021.100423_bib73","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1462-5822.2004.00490.x","article-title":"HGF\/MET signalling protects Plasmodium-infected host cells from apoptosis","volume":"7","author":"Leiri\u00e3o","year":"2005","journal-title":"Cell. Microbiol."},{"key":"10.1016\/j.xcrm.2021.100423_bib74","doi-asserted-by":"crossref","first-page":"e1000201","DOI":"10.1371\/journal.ppat.1000201","article-title":"Kinome-wide RNAi screen implicates at least 5 host hepatocyte kinases in Plasmodium sporozoite infection","volume":"4","author":"Prud\u00eancio","year":"2008","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2021.100423_bib77","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2021.100423_bib78","doi-asserted-by":"crossref","first-page":"96ps35","DOI":"10.1126\/scitranslmed.3001512","article-title":"The emergence of genome-based drug repositioning","volume":"3","author":"Lussier","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100423_bib79","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.drudis.2012.07.014","article-title":"Transcriptional data: a new gateway to drug repositioning?","volume":"18","author":"Iorio","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.xcrm.2021.100423_bib80","doi-asserted-by":"crossref","first-page":"16027","DOI":"10.1038\/cddiscovery.2016.27","article-title":"Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer","volume":"2","author":"Hsieh","year":"2016","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.xcrm.2021.100423_bib81","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/157340911795677602","article-title":"Molecular docking: a powerful approach for structure-based drug discovery","volume":"7","author":"Meng","year":"2011","journal-title":"Curr Comput Aided Drug Des"},{"key":"10.1016\/j.xcrm.2021.100423_bib82","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/wsbm.1337","article-title":"In silico methods for drug repurposing and pharmacology","volume":"8","author":"Hodos","year":"2016","journal-title":"Wiley Interdiscip. Rev. Syst. Biol. Med."},{"issue":"Suppl 12","key":"10.1016\/j.xcrm.2021.100423_bib83","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1186\/1471-2105-9-S12-S14","article-title":"Molecular docking studies of dithionitrobenzoic acid and its related compounds to protein disulfide isomerase: computational screening of inhibitors to HIV-1 entry","volume":"9","author":"Gowthaman","year":"2008","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.xcrm.2021.100423_bib84","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.1021\/jm8008844","article-title":"Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3","volume":"51","author":"Maga","year":"2008","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.xcrm.2021.100423_bib85","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1042\/BCJ20200045","article-title":"Development of novel anti-malarial from structurally diverse library of molecules, targeting plant-like CDPK1, a multistage growth regulator of P. falciparum","volume":"477","author":"Jain","year":"2020","journal-title":"Biochem. J."},{"key":"10.1016\/j.xcrm.2021.100423_bib86","doi-asserted-by":"crossref","first-page":"6195","DOI":"10.1080\/07391102.2020.1794971","article-title":"Network analysis, sequence and structure dynamics of key proteins of coronavirus and human host, and molecular docking of selected phytochemicals of nine medicinal plants","volume":"39","author":"Fatoki","year":"2021","journal-title":"J.\u00a0Biomol. Struct. Dyn."},{"key":"10.1016\/j.xcrm.2021.100423_bib87","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3389\/fimmu.2020.00451","article-title":"Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis","volume":"11","author":"Leukes","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2021.100423_bib88","doi-asserted-by":"crossref","first-page":"e0162407","DOI":"10.1371\/journal.pone.0162407","article-title":"A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer","volume":"11","author":"Vitali","year":"2016","journal-title":"PLoS ONE"},{"key":"10.1016\/j.xcrm.2021.100423_bib89","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1038\/s41467-018-05116-5","article-title":"Network-based approach to prediction and population-based validation of in\u00a0silico drug repurposing","volume":"9","author":"Cheng","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100423_bib90","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov."},{"key":"10.1016\/j.xcrm.2021.100423_bib91","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41563-019-0338-z","article-title":"Exploiting machine learning for end-to-end drug discovery and development","volume":"18","author":"Ekins","year":"2019","journal-title":"Nat. Mater."},{"key":"10.1016\/j.xcrm.2021.100423_bib92","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12936-019-2728-8","article-title":"Two successful decades of Swiss collaborations to develop new anti-malarials","volume":"18","author":"Hooft van Huijsduijnen","year":"2019","journal-title":"Malar. J."},{"key":"10.1016\/j.xcrm.2021.100423_bib93","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nature09107","article-title":"Thousands of chemical starting points for antimalarial lead identification","volume":"465","author":"Gamo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100423_bib94","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.chembiol.2012.01.004","article-title":"Global phenotypic screening for antimalarials","volume":"19","author":"Guiguemde","year":"2012","journal-title":"Chem. Biol."},{"key":"10.1016\/j.xcrm.2021.100423_bib95","doi-asserted-by":"crossref","first-page":"9059","DOI":"10.1073\/pnas.0802982105","article-title":"In silico activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen","volume":"105","author":"Plouffe","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100423_bib96","first-page":"7","article-title":"Cancer Statistics, 2021","volume":"71","author":"Siegel","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2021.100423_bib97","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/21505594.2020.1726570","article-title":"Predictors of outcome in childhood Plasmodium falciparum malaria","volume":"11","author":"Patel","year":"2020","journal-title":"Virulence"},{"key":"10.1016\/j.xcrm.2021.100423_bib98","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12879-021-06018-6","article-title":"Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysis","volume":"21","author":"Shibeshi","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100423_bib99","doi-asserted-by":"crossref","first-page":"eaau9894","DOI":"10.1126\/scisignal.aau9894","article-title":"Targeting of host cell receptor tyrosine kinases by intracellular pathogens","volume":"12","author":"Haqshenas","year":"2019","journal-title":"Sci. Signal."},{"key":"10.1016\/j.xcrm.2021.100423_bib100","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100423_bib101","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11095-020-02851-7","article-title":"Repurposing of Kinase Inhibitors for Treatment of COVID-19","volume":"37","author":"Weisberg","year":"2020","journal-title":"Pharm. Res."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121002858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121002858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:50:12Z","timestamp":1762987812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379121002858"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":101,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2666379121002858"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100423","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Host-directed therapy, an untapped opportunity for antimalarial intervention","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100423"}}